Changes to clone and Extension of Indications (no data) application
Prescription Medicines
Published
Related content
-
Provisional approval pathway: prescription medicines
Information to help sponsors understand the provisional approval pathway for prescription medicines. -
Lapse of provisional registration for Andexxa (andexanet alfa) used for Factor Xa inhibitor (apixaban/rivaroxaban) reversal
ANDEXXA is no longer provisionally approved for use in Australia and has been removed from the Australian Register of Therapeutic Goods (ARTG). -